KALTF - Kalytera Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
11.42M
Enterprise Value 3
14.24M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
2.09
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 2.39
52-Week Change 3-70.43%
S&P500 52-Week Change 315.97%
52 Week High 30.0878
52 Week Low 30.0157
50-Day Moving Average 30.0257
200-Day Moving Average 30.0322

Share Statistics

Avg Vol (3 month) 3293.25k
Avg Vol (10 day) 397.84k
Shares Outstanding 5515.46M
Float 496.25M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Jan 11, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-16.26%
Return on Equity (ttm)-296.44%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-8.78M
Diluted EPS (ttm)-0.0290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)822k
Total Cash Per Share (mrq)0
Total Debt (mrq)3.58M
Total Debt/Equity (mrq)67.86
Current Ratio (mrq)0.29
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-7.2M
Levered Free Cash Flow (ttm)-3.86M